The Next Era in Stroke Prevention

LOUISVILLE Five million people in the United States suffer from atrial fibrillation (AF), a heart condition where the upper chambers

Read more

Digoxin Increases Risk in Patients with Atrial Fibrilation

Digoxin, a drug widely used to treat heart disease, increases the possibility of death when used by patients with a

Read more

Lexington Cardiac Research Foundation Plays Key Role in Development of New Cardiovascular Treatments

LEXINGTON Research is an essential scientific tool to evaluate the latest, most advanced therapeutic and diagnostic methods. Because heart disease

Read more